We are live on ! Find out more
OSRH

OSR Health

Delisted

OSRH was delisted on the 25th of August, 2026.

24 hedge funds and large institutions have $31.2M invested in OSR Health in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

29.4% less ownership

Funds ownership: 62.07%32.67% (-29%)

35% less funds holding

Funds holding: 3724 (-13)

47% less capital invested

Capital invested by funds: $59.3M → $31.2M (-$28.1M)

67% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 18

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
24
Holders Change
-13
Holders Change %
-35.14%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
5
Reduced
7
Closed
18
Calls
Puts
Net Calls
Net Calls Change

OSRH Hedge Fund Activity: Q4 2023 in Review

24 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in OSR Health (OSRH) for Q4 2023, worth a combined $31.2M — down 47% from $59.3M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of OSRH and 6 opened new positions — a net loss of 12 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was Walleye Capital, opening a new position worth an estimated $1.76M. The largest seller was Periscope Capital, cutting an estimated $4.87M.

  • 24 institutional investors held OSR Health (OSRH) as of Q4 2023, down from 37 in Q3 2023.
  • Funds reported $31.2M of OSR Health stock for Q4 2023, down 47% quarter-over-quarter.
  • 6 funds opened new OSR Health positions in Q4 2023 and 18 closed out, a net change of -12 holders.
  • The largest OSR Health buyer in Q4 2023 was Walleye Capital, an estimated $1.76M added.
  • The largest OSR Health seller in Q4 2023 was Periscope Capital, an estimated $4.87M sold.

Based on aggregated 13F filings for Q4 2023.